Skip to main content

PRELIMINARY AGENDA SWISS NORDIC BIO 2019

TIME	PRELIMINARY PROGRAM
08:00-08:30	REGISTRATION Room: Foyer Registration and coffee
08:30-08:45	REGISTRATION Room: Zurich 1 Janique Siffert, Program Manager, Innosuisse – Swiss Innovation Agency Hampus Nilzén, Trade Commissioner & Country Manager, Business Sweden – The Swedish Trade & Invest Council
08:45-09:10	INSPIRATIONAL KEY NOTES Room: Zurich 1 Key note I: WHY INVEST IN A NORDIC OR SWISS BIOTECH? Göran Ando, former Chairman of the Board at Novo Nordisk A/S and currently Senior Advisor at EW Healthcare Partners Key note II: PROTECTION OFFERED BY THE SWISS TAKEOVER RULES Patrick Förg, Head Origination Primary Markets, SIX Christian Fehr, Relationship Manager Primary Markets, SIX
09:10-10:20	PANEL DISCUSSION: FOCUS 2019 – VIEWS & RECOMMENDATIONS FOR SUCCESS IN SWISS & NORDIC TERRITORIES Room: Zurich 1 Moderator: Anders Härfstrand, Board Member at Karolinska Development & Senior Commercial Advisor at HBM Partners AG (Download biography) Panelists: Versant Ventures, Roberto Iacone , EIR/VP Biology (Download biography) Novartis, Hai Zhang, Director Pharma M&A (Download biography) Ernst & Young, Jürg Zürcher, Partner & Biotech/Medtech Leader GSA (Download biography) Karolinska Development, Viktor Drvota, CEO (Download biography) Hadean Ventures, Roger Franklin, Managing Partner (Download biography) EW Healthcare Partners, Göran Ando, Senior Advisor & former Chariman at Novo Nordisk A/S (Download biography)
10:20-10:40	COFFEE BREAK & NETWORKING Room: Foyer
10:40-12:45	COMPANY PRESENTATIONS: INVESTOR & PARTNERING PITCHES Room: Zurich 1 Session sponsors Topic: Medical Devices, Diagnostics 10:40-11:05 Implement Consulting Group –Thomas Storm Thygesen Multiwave Technologies AG - Panos Antonakakis Essential Biotherapeutics - Steven Taub 11:05-11:30 Truly Translational Sweden AB - Karin von Wachenfeldt Pre Diagnostics AS – Håkon Sæterøy Biomedical Bonding - Michael Malkoch Securecell AG - Sandro Waldmeier 11:30-11:55 EUREKA/Eurostars - Janique Siffert Logmore - Niko Polvinen Raytelligence AB - Peter Martinson MedTrace Pharma A/S - Martin Stenfeldt 11:55-12:20 Syneos - Rafal Kokolus Askel Healthcare Oy - Virpi Muhonen Annaida Technologies - Marc Conley Gaurasundar Cerenion Oy - Jukka Kortelainen 12:20-12:45 Hutman Diagnostics - Paul Hofer Sleepiz AG - Max Sieghold OnDosis - Martin Olovsson Room: Zurich 2 Topic: Biotech, Drug Development, Diagnostics 10:40-11:05 AddBio - Tommy Johansson Stayble Therapeutics AB - Andreas Gerward Cell Receptor Inc. - Hans-Åke Fabricius Geneva Biotech Center SA - Robert Slooves 11:05-11:30 Catalyze - Virginia Ballotta SiBreaX - Tim Horlacher Verigraft - Raimund Strehl Topadur Pharma - Reto Naef 11:30-11:55 EUREKA/Eurostars - Inga E. Bruskeland Vitroscope AS - Carlo Kriesi Beactica AB - Per Källblad CorFlow Therapeutics AG - Jon H. Hoem 11:55-12:20 BC Platforms - Anna Wozniak LS CancerDiag - Niklas Lahti Bio-Me - Morten Isaksen Genetic Analysis AS – Emilie Lasson 12:20-12:45 CardiNor AS - Dag Christiansen Elypta - Karl Bergman Prediktor Medical - Espen Krogh
12:45-13:50	NETWORKING LUNCH Room: Foyer
13:50-18:00	ONE-TO-ONE MATCHMAKING MEETINGS Rooms: Zurich 1 & 2 See individual meeting schedules.
18:00-20:00	AFTER CONFERENCE NETWORKING GET-TOGETHER Foyer At your own expense.

MAIN SPONSOR

REGISTRATION

LOGIN

IMPORTANT DEADLINES

End of registration
November 2026

1-to-1 meeting booking closes
November 2026

Event date
November 2026